Letermovir prophylaxis in T-cell-depleted transplants: breakthrough and rebound infections in the postmarketing setting.

Author
Marzolini, Maria A V
Mehra, Varun
Thomson, Kirsty J
Tholouli, Eleni
Bloor, Adrian J C
Parker, Anne
Lovell, Richard
Orchard, Kim
Publicover, Amy
Nicholson, Emma
Publication date
2021-11-09
Subject
Haematology

Metadata
Show full item record
Abstract
No abstract available
Citation
Marzolini MAV, Mehra V, Thomson KJ, Tholouli E, Bloor AJC, Parker A, Lovell R, Orchard K, Publicover A, Nicholson E, Snowden JA, Byrne J, Khan A, Gilleece MH, Errico G, Lozano S, Hurst E, Duncan N, Pirrie J, Crea P, Carpenter B, Pagliuca A, Peggs KS. Letermovir prophylaxis in T-cell-depleted transplants: breakthrough and rebound infections in the postmarketing setting. Blood Adv. 2021 Nov 9;5(21):4500-4503. doi: 10.1182/bloodadvances.2021005637
Type
Article
Handle
http://hdl.handle.net/20.500.14200/5402
Additional Links
https://ashpublications.org/bloodadvances
DOI
10.1182/bloodadvances.2021005637
PMID
34614515
Journal
Blood Advances
Publisher
American Society of Hematology
Collections